Human Vaccine Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast 2024-2028

Human Vaccine Market Size 2024-2028 

The human vaccine market size is forecast to increase by USD 29.1 billion at a CAGR of 9.49% between 2023 and 2028. The market is experiencing significant growth due to several key drivers. The increase in the global pediatric population, particularly in developing countries, is a major factor fueling market growth. Additionally, the continuous research and development (R&D) of novel vaccines to address emerging and re-emerging diseases is driving market expansion. However, concerns about vaccine safety and efficacy, particularly in the context of vaccine hesitancy, pose challenges to market growth. To mitigate these challenges, vaccine manufacturers are focusing on improving vaccine safety and efficacy through advanced technologies and rigorous clinical trials. Overall, the market is expected to witness strong growth in the coming years, driven by these key trends and challenges.

 Request Free Sample

Human vaccines are essential preventive measures against various infectious diseases, including COVID-19, dengue fever, influenza, tuberculosis, malaria, chikungunya, HIV, and more. Toxoid vaccines, made from inactivated or modified toxins, have been in use for decades, while mRNA vaccines, a newer technology, have gained prominence in the fight against COVID-19. Vaccination involves the administration of vaccines to stimulate the immune system, often resulting in side effects such as soreness, swelling, redness, fever, rash, achiness, allergic reactions, and mild symptoms like measles, diphtheria, tetanus, pertussis, rotavirus, and human papillomavirus. Immunization awareness is crucial to mitigate vaccine hesitancy, ensuring herd immunity and protecting individuals and communities from these diseases.

Infectious diseases continue to pose a significant threat to global health, underscoring the importance of ongoing research and development in the human vaccines market.

Market Segmentation

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.

• Route Of Administration
  • Intramuscular
  • Subcutaneous
  • Oral
• End-user
  • Pediatrics
  • Adults
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
  • Asia
  • Rest of World (ROW)

By Route Of Administration Insights

The intramuscular segment is estimated to witness significant growth during the forecast period. Human vaccines play a crucial role in preventing infectious diseases, including COVID-19, Dengue fever, Influenza, Tuberculosis, Malaria, Chikungunya, HIV, and others. Immunology, the branch of science dealing with the immune system, has led to the development of various types of vaccines, such as therapeutic vaccines, conjugate vaccines, recombinant vaccines, live attenuated vaccines, and toxoid vaccines. These vaccines are administered through different routes, primarily intramuscularly, to induce an immune response. The intramuscular segment is expected to witness accelerated growth during the forecast period due to its benefits over the oral route of administration (ROA).

Get a glance at the market share of various segments Request Free Sample

The intramuscular segment accounted for USD 16.37 billion in 2018 and showed a gradual increase during the forecast period.

Regional Insights

North America is estimated to contribute 39% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions Request Free Sample

The global vaccine market is significantly influenced by factors such as vaccine hesitancy and the need for immunization awareness to combat the rising prevalence of diseases, both infectious and chronic. According to the World Health Organization, vaccine hesitancy remains a critical challenge, particularly in the context of diseases like measles, which saw a 30% increase in global cases in 2019. In developed regions like North America, the market is driven by the strong prevalence of diseases such as influenza, hepatitis A, hepatitis B, HIV, measles, malaria, tuberculosis, and non-infectious diseases like cancer. For instance, the US experiences high prevalence rates of influenza annually, particularly from November to February.

The vaccine market caters to a range of diseases, including bacterial diseases like pneumococcal disease, respiratory syncytial virus, dengue tetravalent vaccine, hepatitis, herpes zoster, and gastrointestinal diseases. Despite the availability of vaccines, mortality rates from these diseases remain high, underscoring the importance of continued immunization efforts. The vaccine segment is dominated by a few global players, with the parenteral route being the most common administration method.

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Human Vaccine Market Driver

Increase in pediatric population is the key driver of the market. Human vaccines play a crucial role in preventing the spread of infectious diseases such as COVID-19, Dengue fever, Influenza, Tuberculosis, Malaria, Chikungunya, HIV, and others. Immunology has made significant strides in developing various types of vaccines, including therapeutic vaccines, technology-driven conjugate vaccines, recombinant vaccines, and live attenuated vaccines. These vaccines help protect against various diseases and reduce the risk of complications and adverse reactions such as soreness, swelling, redness, fever, rash, achiness, and allergic reactions. The need for vaccines is particularly important for pediatric populations, who are more susceptible to infectious diseases due to weak immune systems. Combination vaccines are increasingly being used to reduce the number of shots and healthcare center visits, saving time and money.

The increasing pediatric population in developed countries, driven by immigration, will continue to demand more vaccines. However, the global population growth will be driven more by an aging population and declining birth rates. In contrast, developing regions continue to experience high birth rates due to a lack of education, limited awareness of modern contraception methods, improper implementation of birth control programs, and low income. Vaccines for diseases such as Anthrax, meningococcal disease, and others are essential public health initiatives that require strict regulatory requirements. Vaccines for diseases like measles, diphtheria, tetanus, pertussis, rotavirus, human papillomavirus, and cervical cancer have been instrumental in reducing morbidity and mortality.

The recent development of mRNA vaccines for COVID-19 has shown the potential for rapid vaccine development and deployment in response to emerging diseases. Healthcare organizations play a vital role in ensuring the availability and accessibility of vaccines to the population. Education and awareness programs are essential to ensure the effective use and administration of vaccines.

Human Vaccine Market Trends

R and D of novel vaccines is the upcoming trend in the market. The market is experiencing significant growth due to the increasing prevalence of infectious diseases and the need to develop vaccines for life-threatening conditions such as cancer and HIV. Infectious diseases like COVID-19, Dengue fever, Influenza, Tuberculosis, Malaria, Chikungunya, and Anthrax continue to pose a significant health risk, necessitating the development of vaccines. Immunology research has led to the creation of various types of vaccines, including conjugate vaccines, recombinant vaccines, live attenuated vaccines, and toxoid vaccines. These vaccines have been instrumental in preventing and treating diseases, with notable successes in eradicating or controlling diseases like measles, diphtheria, tetanus, pertussis, rotavirus, and human papillomavirus, which contribute to cervical cancer.

The market is also witnessing the emergence of therapeutic vaccines and mRNA vaccines, which hold great potential in treating and preventing diseases. Vaccination programs, initiated by health care organizations and public health initiatives, are essential in ensuring regulatory requirements are met and pediatric vaccinations are administered. Despite potential side effects such as soreness, swelling, redness, fever, rash, achiness, and allergic reactions, the benefits of vaccines far outweigh the risks. Vendors are continually investing in research and development to create effective and safe vaccines to combat the ongoing threat of infectious diseases and other life-threatening conditions.

Human Vaccine Market Challenge

Concerns about the safety of vaccines is key challenge affecting the market growth. Human vaccines play a crucial role in preventing infectious diseases such as COVID-19, Dengue fever, Influenza, Tuberculosis, Malaria, Chikungunya, HIV, and others. Immunology has made significant strides in developing various types of vaccines, including therapeutic vaccines, conjugate vaccines, recombinant vaccines, and live attenuated vaccines. These drugs are essential for preventing the spread of diseases and saving lives. However, like all medical interventions, vaccines may have side effects. Common side effects include injection site reactions, mild fever, fatigue, pain, and fainting. More serious effects, such as severe hemorrhagic dengue fever, are associated with specific vaccines. Vaccination is a critical public health initiative, and health care organizations and educational institutions play a vital role in ensuring regulatory requirements are met.

Vaccines for diseases like measles, diphtheria, tetanus, pertussis, rotavirus, human papillomavirus, and cervical cancer have been instrumental in reducing morbidity and mortality. MRNA vaccines have recently gained prominence due to their effectiveness against COVID-19. Despite the rare occurrence of side effects, the benefits of vaccination far outweigh the risks. It is essential to remember that vaccines are safe and effective tools for preventing infectious diseases and protecting individual and population health.

Exclusive Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

 Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Astellas Pharma Inc. - The company is a leading provider of human vaccines, including Acam2000, BAT, and BioThrax. These vaccines are essential in preventing various diseases and maintaining public health.

The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• AstraZeneca Plc
• Bavarian Nordic AS
• Bharat Biotech Ltd.
• BioNTech SE
• CanSino Biologics Inc.
• CSL Ltd.
• Daiichi Sankyo Co. Ltd.
• Emergent BioSolutions Inc.
• GlaxoSmithKline Plc
• Gradalis Inc.
• Inovio Pharmaceuticals Inc.
• Johnson and Johnson
• Merck and Co. Inc.
• Mitsubishi Chemical Group Corp.
• Moderna Inc.
• Novavax Inc.
• Pfizer Inc.
• Serum Institute of India Pvt. Ltd.
• Sanofi SA

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Research Analyst Overview

Human vaccines are essential in preventing the spread of infectious diseases and saving lives. The global human vaccines market has witnessed significant growth due to the ongoing COVID-19 pandemic and the development of vaccines for various diseases. The market includes various types of vaccines such as conjugate vaccines, recombinant vaccines, live attenuated vaccines, toxoid vaccines, and therapeutic vaccines. Some of the major diseases addressed by human vaccines include COVID-19, dengue fever, influenza, tuberculosis, malaria, chikungunya, HIV, and Hepatitis B. Vaccines work by stimulating the body's immune system to produce immunity to specific diseases. Common side effects of vaccination include soreness, swelling, redness, fever, rash, achiness, and allergic reactions.

Vaccines for diseases like anthrax, meningococcal disease, and pediatric diseases such as measles, diphtheria, tetanus, pertussis, rotavirus, and human papillomavirus are important public health initiatives. Regulatory requirements and education play a crucial role in ensuring the safety and efficacy of human vaccines. MRNA vaccines have emerged as a new technology in vaccine development, offering potential advantages in terms of faster development and production times. Drugs and vaccines are essential components of healthcare organizations' offerings, and vaccines are a vital tool in preventing the spread of infectious diseases and saving lives.

Request Free Sample

What are the Key Data Covered in this Market Research and Growth Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting between 2024 and 2028
• Precise estimation of the size of the market  and its contribution of the market in focus to the parent market
• Accurate predictions about upcoming market growth and trends and changes in consumer behaviour
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch